Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2009
11/19/2009WO2009007411A3 Inhibition of age formation
11/19/2009WO2008128049A3 Tetrahydrobiopterin compositions and methods of measuring
11/19/2009US20090286858 Assays for modulators of asparaginyl hydroxylase
11/19/2009US20090286840 Polo-like kinase inhibitors such as 5-(5-Amino-2H-pyrazol-3-yl)-3-[1-(2-chloro-phenyl)-ethoxy]-thiophene-2-carboxylic acid amide, useful for treating or preventing autoimmune, inflammatory, proliferative or hyperproliferative disease, a neurodegenerative disease, or an immunologically-mediated disease
11/19/2009US20090286816 Modulators of metabolism and the treatment of disorders related thereto
11/19/2009US20090286812 GPR119 Receptor Agonists
11/19/2009US20090286811 Fused pyrimidineone compounds as trpv3 modulators
11/19/2009US20090286800 Glucokinase Activators
11/19/2009US20090286791 Amide Compounds
11/19/2009US20090286786 Compounds having a 4-pyridylalkylthio group as a substituent
11/19/2009US20090286780 2-oxochromene derivatives
11/19/2009US20090286776 Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
11/19/2009US20090286774 Purinone derivatives as hm74a agonists
11/19/2009US20090286767 Substituted quinolin-4-ylamine analogues
11/19/2009US20090286758 Substituted n-phenyl-5-phenyl-pyrazolin-3-yl amides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity
11/19/2009US20090286751 Progression inhibitor for disease attributed to abnormal accumulation of liver fat
11/19/2009US20090286735 Method for administering glp-1 molecules
11/19/2009US20090286724 Aggregable glp-1 analogue and sustained-release pharmaceutical composition
11/19/2009US20090286723 Hybrid Polypeptides with Selectable Properties
11/19/2009US20090286716 Soluble Pharmaceutical Compositions for Parenteral Administration Comprising a GLP-1 Peptide and an Insulin Peptide of Short Time Action for Treatment of Diabetes and Bulimia
11/19/2009US20090286715 Pharmaceutical Composition
11/19/2009US20090285911 Cynara scolymus extracts, the use thereof and formulations containing them
11/19/2009US20090285822 Prevention and treatment of amyloidogenic disease
11/19/2009US20090285816 Albumin Fusion Proteins
11/19/2009US20090285809 Prevention and treatment of amyloidogenic diseases
11/19/2009CA2740029A1 Pharmaceutical composition for treatment of fibromyalgia
11/19/2009CA2724214A1 Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
11/19/2009CA2724133A1 Medicine consisting of concomitant use or combination of dpp-iv inhibitor and other diabetic medicine
11/19/2009CA2724116A1 Glucokinase activators
11/19/2009CA2724055A1 Glucocorticoid receptor agonist comprising 2,2,4-trimethyl-6-phenyl-1,2 -dihydroquinoline derivatives having substituted oxy group
11/19/2009CA2724048A1 Oral preparation
11/19/2009CA2724023A1 Salicylate conjugates useful for treating metabolic disorders
11/19/2009CA2723987A1 Use of angiogenin or angiogenin agonists for treating diseases and disorders
11/19/2009CA2723455A1 Lipoprotein lipase-activating compositions comprising benzene derivates
11/19/2009CA2722600A1 Anti-hepcidin antibodies and methods of use
11/18/2009EP2119785A1 Novel peptides
11/18/2009EP2119738A1 Polyethylene glycol derivative
11/18/2009EP2119719A1 Thiazepine derivative
11/18/2009EP2119717A1 8-[3-amino-piperidin-1-yl]-xanthins, their production and utilisation as DPP IV inhibitors
11/18/2009EP2119716A1 Aza-bridged-ring compound
11/18/2009EP2119715A1 Benzimidazole derivative and its use as aii receptor antagonist
11/18/2009EP2119702A1 Amide derivative
11/18/2009EP2119690A1 Radiolabelled MMP selective compounds
11/18/2009EP2119446A1 Epithelium improving agent
11/18/2009EP2119445A1 Prophylactic agent for autoimmune disease
11/18/2009EP2119443A1 Composition for prevention or treatment of disease associated with thrombus or embolus
11/18/2009EP2119441A1 Use of angiotensin II receptor antagonists in order to increase insulin sensitivity
11/18/2009EP2119438A1 Bone metabolism ameliorating agent
11/18/2009EP2118103A2 Azaindole derivatives as cftr modulators
11/18/2009EP2118089A1 Indol-2-yl-piperazin-1-yl-methanone derivatives
11/18/2009EP2118074A1 Compounds for the prevention and treatment of cardiovascular diseases
11/18/2009EP2118068A1 Indazoles used to treat estrogen receptor beta mediated disorders
11/18/2009EP2118057A1 (indol-4-yl)- or (indol-5-yl)-piperazinylmethanone derivatives for the treatment of obesity
11/18/2009EP2117561A1 Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines
11/18/2009EP2117550A1 Use of ranolazine for the treatment of non-coronary microvascular diseases
11/18/2009EP2117549A1 Use of ranolazine for the treatment of coronary microvascular diseases
11/18/2009EP2117527A1 Methods for the treatment of senile dementia of the alzheimer's type
11/18/2009EP2117526A2 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
11/18/2009EP2117509A1 Use of ranolazine for the treatment of cardiovascular diseases
11/18/2009EP1910359B1 PYRIDO [2 , 3-D]PYRIMIDINE-2 , 4-DIAMINE COMPOUNDS AS PTPlB INHIBITORS
11/18/2009EP1910340B1 Indazolecarboxamide derivatives as 5ht4 receptor agonists
11/18/2009EP1873148B1 Pharmaceutical compositions containing crystalline salts of 7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3R,5S)-3,5-dihydroxyhept-6-enoic acid
11/18/2009EP1789402B1 2-{-3-2-(phenyl)-oxazol-4-ylmethoxymethyl!-cyclohexylmethoxy };-propionic acid derivatives used as ppar ligandes (peroxisome proliferator-activated receptors) for the treatment of hyperlipidaemie and diabetes
11/18/2009EP1490064B1 Substituted pyridinones as modulators of p38 map kinase
11/18/2009EP1421071B1 Substituted piperazine and diazepane derivaives as histamine h3 receptor modulators
11/18/2009EP1413303B1 Swine growth promoters and method of promoting swine growth
11/18/2009EP1397357B9 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
11/18/2009EP1370525B1 Biguanide derivatives
11/18/2009EP1358172B1 Amino ceramide-like compounds and therapeutic methods of use
11/18/2009EP0957901B1 Pharmaceutical preparations of glutathione and methods of administration thereof
11/18/2009CN101583627A Methods for reducing phosphate absorption
11/18/2009CN101583612A Azetidinone derivatives and methods of use thereof
11/18/2009CN101583598A Novel indole derivative having inhibitory activity on i kappa b kinase ss
11/18/2009CN101583597A Sulfonamide derivatives as liver carnitine palmitoyl transferase (L-CPT1)
11/18/2009CN101583358A Use of PKC inhibitors in transplantation
11/18/2009CN101580871A Method for screening new drug for lowering cholesterol based on analysis of change of NPC1L1 protein subcellular localization
11/18/2009CN101580554A Anoectochilus roxburghii polyose, applications thereof in pharmacy and preparation method of anoectochilus roxburghii polyose
11/18/2009CN101580497A Statins antilipemic drugs furazan nitroxides derivates and preparation method thereof
11/18/2009CN101580466A Preparation method of sodium salt of pravastatin
11/18/2009CN101579510A Lipid-regulating grain and application thereof in preparing medicament for preventing and curing hyperlipidemia accompanied with abnormal hepatic function
11/18/2009CN101579490A Health product capable of decreasing blood glucose and preparation method thereof
11/18/2009CN101579483A Chinese medicine composition for treating diabetes and complication and preparation method thereof
11/18/2009CN101579477A Traditional Chinese medicine foot soaping liquid for treating diabetes
11/18/2009CN101579476A Medicament for treating various types of diabetes by repairing damaged islet cells with Miao medicament CG606 tea pigment and preparation method of CG606 tea pigment
11/18/2009CN101579471A Medicine for curing diabetes
11/18/2009CN101579466A Medicine composition for reducing blood sugar and blood fat, and curing diabetes
11/18/2009CN101579465A Medicine composition for reducing blood sugar and blood fat, and curing diabetes
11/18/2009CN101579464A Medicine composition for reducing blood sugar and blood fat, and curing diabetes
11/18/2009CN101579463A Medicine composition for reducing blood sugar and blood fat, and curing diabetes
11/18/2009CN101579460A Weight loss pill for external application
11/18/2009CN101579447A Pharmaceutical composition for reducing blood sugar and blood fat
11/18/2009CN101579446A Pharmaceutical composition for reducing blood sugar and blood fat
11/18/2009CN101579445A Pharmaceutical composition for reducing blood sugar and blood fat
11/18/2009CN101579444A Pharmaceutical composition for lowering blood sugar and blood fat
11/18/2009CN101579443A Pharmaceutical composition for lowering blood sugar and blood fat
11/18/2009CN101579442A Pharmaceutical composition for lowering blood sugar and blood fat
11/18/2009CN101579441A Pharmaceutical composition for lowering blood sugar and blood fat
11/18/2009CN101579438A Pharmaceutical composition for lowering blood sugar
11/18/2009CN101579437A Medicinal dripping pill for treating adiposity
11/18/2009CN101579435A Medicinal composition for treating adiposity and preparation method thereof
1 ... 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 ... 1298